Speeches by Ranger.

“Thank you very much, Chair, and thank you to members of the Committee. As many of us will have heard, the findings of the interim Milburn report into young people and work shed light on what I believe is a national scandal, showing the long-term neglect of over a million young people classed as NEET. The review showcas…”

“I fully appreciate that. Last time, you were kind enough to grant me a debate in Westminster Hall on careers advice for young people. It was very well supported, and the people who signed the application did turn up. I hope to emulate that.”

“I would definitely consider it. As you know, attendance is always a challenge on a Thursday, which is the downside, but you raise a good point. I think we need to have this debate relatively soon. We have the full report coming out in the autumn—October, I believe—and I assume that the Government will issue some kind o…”

“It is my second.”

“Thank you very much. Josh Newbury made representations.”

“I am guessing from your answers that you do not think that the communities you have visited have received sufficient support to mitigate the risks of metal mine pollution. Were there any examples where sufficient support has been put in place that you could point to?”

“Good afternoon, both. This question, which follows on from that, is for both of you, starting with Laura. Do you think that the communities you have spoken to in the last year have received sufficient information to help them understand where the contaminated land is or may be?”

“That is interesting. I am quite interested in your point about signs. On the trip on Monday, we were talking to various people from the Mining Remediation Authority and NRW about signs going up. This was on spoil at Wemyss, I think, was it not? We were interested that there were no signs at all, and there was a caution…”

“Would you say that your experience of putting that in place is making IPFR decision more robust and prompt? Is it having an effect?”

“Bearing in mind what you have just said, is there anything in consideration about how we make that process more robust and efficient? Is anything happening to look at that?”

“In yesterday’s session, we heard about delays before getting to the decision point for IPFRs. One of the delays mentioned was around acquiring the membership for the whole panel to get together. Is the process around IPFR decision making too reliant on individuals having to turn up and be there?”

“Obviously, in England we are seeing lots of reforms in the NHS: changes to NHS England, the combination of ICBs, a big churn in staff and the anticipated move towards more community-based work, away from hospitals. Similarly, we have a new Government in Wales, who have suggested changes along similar lines, moving care…”

“Good afternoon and thank you all for coming today. Iolo, who makes up the membership of IPFR panels?”

“You have touched on the second part to my question already, so I will bring that in now. Sarah Walter, the deputy chief executive of the NHS Alliance, said in recent evidence to us that there has been a loss “in the commissioning capability within the NHS.” That was a point you were talking to. How do you anticipate th…”

“Is work happening to make sure that focus is maintained while ICBs go through their reforms? That is probably work from their side, but are you aware of it happening? Is that a key thing that they are doing during their reforms and their thinking?”

“Good afternoon, all. This is a question for Suzanne and Abigail. Your health boards both provide specialist care to patients from England, as was mentioned earlier. How do the processes for receiving patients from England, and discharging them, differ from the processes for Welsh patients?”

“I want to turn to the impact of the changes on the structure of NHS England. How do you anticipate the changes to ICBs in England impacting on cross-border healthcare? Is there a risk that ICBs with bigger geographic scopes will lose sight of the needs of patients across the border? There is an increasing focus in Engl…”

“To be clear, there is no difference in patient experience or from an admin or bureaucracy point of view.”

“Are the patients recorded in your waiting time statistics in exactly the same way as a Welsh patient, or is there a difference?”

“Good afternoon, all. I am sorry I missed the start of the session. On a similar vein, I will concentrate on the cancer treatment waiting times in Betsi Cadwaladr. Clara, Betsi is obviously facing some of the most challenging circumstances around cancer waiting times. Are cross-border healthcare solutions being explored…”